CRISPR/Cas9‐mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV‐positive hepatocellular carcinoma cells
Jia Song(Ministry of Education of the People's Republic of China), Bixiang Zhang(Ministry of Education of the People's Republic of China)
Cited by 54
Related Papers
Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment
|Molecular Cancer|2025|42
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
|The Lancet. Gastroenterology & hepatology|2025|39
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway
|Cellular Oncology|2022|35
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism
|Pharmacological Research|2023|27